1-4 of 4
John DeCoteau
Close
Sort by
Journal Articles

Immune Repertoire Analysis of Multiple Myeloma Research Samples Using NGS Characterization of Multiple B Cell Receptors in a Single Reaction

Geoffrey Lowman, Landon Pastushok, Karen Mochoruk, Wayne Hill, Michelle Toro, Loni Pickle, Carolina Gonzalez, Stephanie Ostresh, Shrutii Sarda, Chenchen Yang, Julie Stakiw, Mark J. Bosch, Hadi Alphonse Goubran, Ronald Geyer, John DeCoteau
Journal: Blood
Blood (2021) 138 (Supplement 1): 1881.
https://doi.org/10.1182/blood-2021-152987
Published: 2021
Journal Articles

Strategies to Re-Express Epigenetically-Silenced Tumor Suppressor Genes Converge on the Requirement for Inhibition of the Histone Methyltransferase SUV39H1.

Asha Lakshmikuttyamma, PhD, Stuart Scott, PhD, David P. Sheridan, MD, John DeCoteau, MD, Ron Geyer, PhD
Journal: Blood
Blood (2008) 112 (11): 3357.
https://doi.org/10.1182/blood.V112.11.3357.3357
Published: 2008
Journal Articles

RIZ1 Is Downregulated during CML Progression and Displays Tumor Suppressor Properties in CML Cell Lines.

Naoto Takahashi, MD, PhD, Elodie Pastural, PhD, Robert Lowsky, MD, Emina Torlakovic, Magdalena Czader, MD, Guillermo Garcia-Manero, MD, Hesham M. Amin, MD, C. Ronald Geyer, PhD, John DeCoteau, MD
Journal: Blood
Blood (2006) 108 (11): 2134.
https://doi.org/10.1182/blood.V108.11.2134.2134
Published: 2006
Journal Articles

RIZ1 Tumor Suppressor Regulates IGF-1 Autocrine Loop To Control Cell Proliferation, Apoptosis, and Differentiation in Chronic Myeloid Leukemia Blast Crisis Cell Lines.

Naoto Takahashi, MD, PhD, Wei-Feng Dong, MD, PhD, Matthew Bainbridge, MSc, Andrea Hull, MD, Elodie Pastural, PhD, Derek Pearson, MD, David Sheridan, MD, John DeCoteau, MD, C. Ron Geyer, PhD
Journal: Blood
Blood (2005) 106 (11): 1208.
https://doi.org/10.1182/blood.V106.11.1208.1208
Published: 2005